Aziz Sawaf
Net worth: 6 M $ as of 2026-08-30
Net worth: 6 M $ as of 2026-08-30
Mr. Aziz Sawaf, CFA MBA, is a Chief Financial Officer & SVP-Operations Strategy at Theravance Biopharma, Inc. He is on the Board of Directors at California Life Sciences Association.
He received his undergraduate degree from the University of Arizona, a graduate degree from The Johns Hopkins University and an MBA from USC Marshall School of Business.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-08-19 | 336,841 ( 0.65% ) | 6 M $ | 2026-08-30 |
| Companies | Position | Start |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Director of Finance/CFO | 2022-12-31 |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Director/Board Member | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USC Marshall School of Business
USC Marshall School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
California Life Sciences Association
California Life Sciences Association Miscellaneous Commercial ServicesCommercial Services Acts as a trade association which represents the life sciences industry of California | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions